MAY 19: PROSTABLOG NZ: Someone’s making a lot of money from prostate cancer sufferers, as a report analysing world-wide markets for prostate cancer therapeutics (mostly hormonal therapies) – including 138 companies – shows. READ MORE>
Posts Tagged ‘AstraZeneca PLC.’
PROSTATE PROFITS: Report analyses drug makers who make cancer treatments
Posted in New prostate drugs, PROSTATE CANCER, Prostate drugs, Treatment debate, tagged (USA) Inc., Abbott Laboratories, AEterna Zentaris Inc., ALZA Corporation, Amgen Inc., AstraZeneca PLC., Bristol-Myers Squibb Company, Cell Genesys Inc., Dendreon Corporation, EUSA Pharma, F. Hoffmann-La Roche Ltd., Genentech Inc., GlaxoSmithKline Plc., hormonal therapies, Immunomedics, Inc., Indevus Pharmaceuticals Inc., LLC, Medimmune, Novartis AG, OSI Pharmaceuticals, Paladin Labs Inc., Pfizer Inc., Progenics Pharmaceuticals, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate drug makers, prostate drug market, Reportlinker, Sanofi-Aventis SA, Spectrum Pharmaceuticals, Takeda Pharmaceutical Company Limited, World Prostate Cancer Therapeutics Market on May 19, 2009| Leave a Comment »